Disclosures for "Clinical Updates from the Elsunersen Emergency Use Program: A Novel ASO for Treatment of Early Onset SCN2A Developmental and Epileptic Encephalopathy"
-
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharming Group. The institution of Dr. Wagner has received research support from Novartis. Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving as a speaker with Jazz Pharmaceutics. Dr. Wagner has received personal compensation in the range of $0-$499 for serving as a speaker with UCB. Dr. Wagner has received personal compensation in the range of $0-$499 for serving as a speaker with Desitin.
-
Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Desitin. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme.
-
Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
-
Dr. Troedson has nothing to disclose.
-
The institution of Dr. Howell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Howell has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Howell has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCN2A Australia. The institution of Dr. Howell has received research support from UCB. Dr. Howell has a non-compensated relationship as a Prior research support, ongoing collaboration with Praxis Precision Medicines that is relevant to AAN interests or activities.
-
Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi Therapeutics.
-
Dr. Frizzo has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Frizzo has stock in Praxis Precision Medicines.
-
Mr. Horton has received personal compensation for serving as an employee of Praxis Precision Medicines. Mr. Horton has stock in Praxis Precision Medicines.
-
Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
-
Mr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc..
-
Dr. motel has nothing to disclose.
-
Mr. Spar has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.